485 related articles for article (PubMed ID: 29981801)
1. Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.
Tao P; Zhu J; Mahalingam M; Batra H; Rao VB
Adv Drug Deliv Rev; 2019 May; 145():57-72. PubMed ID: 29981801
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine.
Tao P; Li Q; Shivachandra SB; Rao VB
Methods Mol Biol; 2017; 1581():255-267. PubMed ID: 28374254
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach.
Wu J; Tu C; Yu X; Zhang M; Zhang N; Zhao M; Nie W; Ren Z
J Virol Methods; 2007 Jan; 139(1):50-60. PubMed ID: 17081627
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
5. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
6. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
[TBL] [Abstract][Full Text] [Related]
7. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.
O'Rourke JP; Peabody DS; Chackerian B
Curr Opin Virol; 2015 Apr; 11():76-82. PubMed ID: 25829254
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the small outer capsid protein, Soc, on bacteriophage T4: a novel system for high density display of multiple large anthrax toxins and foreign proteins on phage capsid.
Li Q; Shivachandra SB; Zhang Z; Rao VB
J Mol Biol; 2007 Jul; 370(5):1006-19. PubMed ID: 17544446
[TBL] [Abstract][Full Text] [Related]
9. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
10. Multicomponent anthrax toxin display and delivery using bacteriophage T4.
Shivachandra SB; Li Q; Peachman KK; Matyas GR; Leppla SH; Alving CR; Rao M; Rao VB
Vaccine; 2007 Jan; 25(7):1225-35. PubMed ID: 17069938
[TBL] [Abstract][Full Text] [Related]
11. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
[TBL] [Abstract][Full Text] [Related]
12. T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines.
Li M; Chen C; Wang X; Guo P; Feng H; Zhang X; Zhang W; Gu C; Zhu J; Wen G; Feng Y; Xiao L; Peng G; Rao VB; Tao P
Antiviral Res; 2023 Sep; 217():105688. PubMed ID: 37516153
[TBL] [Abstract][Full Text] [Related]
13. Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination.
Mohsen MO; Gomes AC; Cabral-Miranda G; Krueger CC; Leoratti FM; Stein JV; Bachmann MF
J Control Release; 2017 Apr; 251():92-100. PubMed ID: 28257987
[TBL] [Abstract][Full Text] [Related]
14. Display of a PorA peptide from Neisseria meningitidis on the bacteriophage T4 capsid surface.
Jiang J; Abu-Shilbayeh L; Rao VB
Infect Immun; 1997 Nov; 65(11):4770-7. PubMed ID: 9353063
[TBL] [Abstract][Full Text] [Related]
15. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
Basu R; Zhai L; Contreras A; Tumban E
Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.
Patterson DP; Rynda-Apple A; Harmsen AL; Harmsen AG; Douglas T
ACS Nano; 2013 Apr; 7(4):3036-44. PubMed ID: 23540530
[TBL] [Abstract][Full Text] [Related]
17. Bacteriophage T4 capsid packaging and unpackaging of DNA and proteins.
Mullaney JM; Black LW
Methods Mol Biol; 2014; 1108():69-85. PubMed ID: 24243241
[TBL] [Abstract][Full Text] [Related]
18. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
19. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8
Sharma J; Carson CS; Douglas T; Wilson JT; Joyce S
Methods Mol Biol; 2022; 2412():367-398. PubMed ID: 34918256
[TBL] [Abstract][Full Text] [Related]
20. Particle-based platforms for malaria vaccines.
Wu Y; Narum DL; Fleury S; Jennings G; Yadava A
Vaccine; 2015 Dec; 33(52):7518-24. PubMed ID: 26458803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
